Animal models of atherosclerosis
- PMID: 22383700
- PMCID: PMC3331926
- DOI: 10.1161/ATVBAHA.111.237693
Animal models of atherosclerosis
Abstract
Atherosclerosis is a chronic inflammatory disorder that is the underlying cause of most cardiovascular disease. Both cells of the vessel wall and cells of the immune system participate in atherogenesis. This process is heavily influenced by plasma lipoproteins, genetics, and the hemodynamics of the blood flow in the artery. A variety of small and large animal models have been used to study the atherogenic process. No model is ideal as each has its own advantages and limitations with respect to manipulation of the atherogenic process and modeling human atherosclerosis or lipoprotein profile. Useful large animal models include pigs, rabbits, and nonhuman primates. Due in large part to the relative ease of genetic manipulation and the relatively short time frame for the development of atherosclerosis, murine models are currently the most extensively used. Although not all aspects of murine atherosclerosis are identical to humans, studies using murine models have suggested potential biological processes and interactions that underlie this process. As it becomes clear that different factors may influence different stages of lesion development, the use of mouse models with the ability to turn on or delete proteins or cells in tissue specific and temporal manner will be very valuable.
Similar articles
-
Pig and Mouse Models of Hyperlipidemia and Atherosclerosis.Methods Mol Biol. 2022;2419:379-411. doi: 10.1007/978-1-0716-1924-7_24. Methods Mol Biol. 2022. PMID: 35237978
-
Murine atherosclerosis. Part III.Curr Drug Targets. 2008 Mar;9(3):173. doi: 10.2174/138945008783755548. Curr Drug Targets. 2008. PMID: 18336234
-
The immune system and murine atherosclerosis.Curr Drug Targets. 2007 Dec;8(12):1297-306. doi: 10.2174/138945007783220669. Curr Drug Targets. 2007. PMID: 18220706 Review.
-
Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.Methods Mol Biol. 2009;517:381-99. doi: 10.1007/978-1-59745-541-1_23. Methods Mol Biol. 2009. PMID: 19378021
-
Natural killer T cells in lipoprotein metabolism and atherosclerosis.Thromb Haemost. 2011 Nov;106(5):814-9. doi: 10.1160/TH11-05-0336. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21946866 Free PMC article. Review.
Cited by
-
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.Sci Transl Med. 2016 Apr 6;8(333):333ra50. doi: 10.1126/scitranslmed.aad6100. Sci Transl Med. 2016. PMID: 27053774 Free PMC article.
-
Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Dis Model Mech. 2013 Mar;6(2):312-22. doi: 10.1242/dmm.010413. Epub 2013 Feb 8. Dis Model Mech. 2013. PMID: 23471910 Free PMC article. Review.
-
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.JACC Cardiovasc Imaging. 2019 Oct;12(10):2015-2026. doi: 10.1016/j.jcmg.2018.07.027. Epub 2018 Oct 17. JACC Cardiovasc Imaging. 2019. PMID: 30343086 Free PMC article.
-
Protein Phosphatase 2A Deficiency in Macrophages Increases Foam Cell Formation and Accelerates Atherosclerotic Lesion Development.Front Cardiovasc Med. 2022 Jan 18;8:745009. doi: 10.3389/fcvm.2021.745009. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35118139 Free PMC article.
-
Circulating gut microbiota-related metabolites influence endothelium plaque lesion formation in ApoE knockout rats.PLoS One. 2022 May 6;17(5):e0264934. doi: 10.1371/journal.pone.0264934. eCollection 2022. PLoS One. 2022. PMID: 35522651 Free PMC article.
References
-
- Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 1999;340:115–126. - PubMed
-
- Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104:503–516. - PubMed
-
- Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol. 2010;134:33–46. - PubMed
-
- VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2004;24:12–22. - PubMed
-
- Yang X, Peterson L, Thieringer R, Deignan JL, Wang X, Zhu J, Wang S, Zhong H, Stepaniants S, Beaulaurier J, Wang IM, Rosa R, Cumiskey AM, Luo JM, Luo Q, Shah K, Xiao J, Nickle D, Plump A, Schadt EE, Lusis AJ, Lum PY. Identification and validation of genes affecting aortic lesions in mice. J Clin Invest. 2010;120:2414–2422. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials